Bangkok Genomics Innovation Public (BKGI.BK) Earnings Analysis
Bangkok Genomics Innovation Public (BKGI.BK) next reports earnings on 2026-08-19. It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E 17.53.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BKGI.BK next report earnings?
| Next earnings date | 2026-08-19 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
BKGI.BK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-15 | 0.0521 THB | n/a | n/a | n/a |
| 2026-02-25 | 0.0433 THB | n/a | n/a | n/a |
| 2025-08-13 | 0.00716 THB | 0.01 THB | -28.4% | Miss |
| 2025-05-15 | 0.01354 THB | 0.01 THB | +35.4% | Beat |
| 2025-02-26 | 0.03 THB | 0.02 THB | +50% | Beat |
| 2024-08-14 | 0.02301 THB | 0.02 THB | +15% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
BKGI.BK valuation and analyst view
| Trailing P/E | 17.53 |
|---|---|
| Trailing EPS | 0.1141 THB |
| Price / book | 2.06 |
| Dividend yield | 2.50% |
| Market cap | 1.21B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Bangkok Genomics Innovation Public (BKGI.BK)'s next earnings date?
Bangkok Genomics Innovation Public is next scheduled to report on 2026-08-19.
Did BKGI.BK beat earnings last quarter?
Consensus estimate data was not available for BKGI.BK's 2026-05-15 report.
What is BKGI.BK's earnings track record?
Over the last 4 reported quarters with consensus data, BKGI.BK beat estimates 3 times (75%).
What is BKGI.BK's current P/E ratio and EPS?
BKGI.BK trades at a trailing P/E of 17.53 on trailing EPS of 0.11410157833333333 THB.
What do analysts rate BKGI.BK?
BKGI.BK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.